Benevolent News Hub

Challenges of designing an AI platform for Drug Discovery w/ Marek Kultys
Our Senior Product Designer explores the design process at BenevolentAI where he builds user facing tools that help our scientists discover and develop new medicines.
Mar 17, 2020
International Women’s Day: A Conversation with Four Female Colleagues
For International Women’s Day we hosted a fireside chat with four of our female colleagues to learn about their experiences, successes and the challenges they've faced in a largely male dominated industry.
Mar 11, 2020
How historically neglecting sex differences has impacted women’s health
Sex differences have historically been neglected in clinical research, design and practice. For International Women’s Day, we explored the implications of this ‘one size fits all’ approach on women’s health.
Mar 8, 2020
Medical data: the key to unlocking the true potential of AI in healthcare
The biomedical research data-gap risks worsening health inequality, and will be exacerbated in the age of AI. In a recent panel at Benevolent, technology and healthcare experts discussed the data diversity issue and proposed solutions.
Mar 3, 2020
Teaming up to fuel scientific discovery in CCM research
We partnered with UC San Diego to investigate new approaches to develop non-invasive therapeutic treatments for CCM. Benevolent’s Senior Principal Scientist shares insights into his work to use AI to identify new targets associated with this disease.
Feb 27, 2020
MIT Technology Review names BenevolentAI as a top 10 breakthrough tech
We’re proud to be recognised on this prestigious list for our work in AI-driven chemical design. Our compound design is based upon complex multiparametric optimisations which aim to cut the time and cost of designing a drug.
Feb 26, 2020